4/A: Artivion Inc. Executive Amends SEC Filing to Correct Stock Sale Reporting Errors

Andrew M. Green, VP of Regulatory at Artivion Inc., filed an amended SEC Form 4/A to correct errors in the number of shares sold to cover tax withholding obligations upon the vesting of performance stock units.

Summary

• Andrew M. Green, VP of Regulatory at Artivion Inc., filed an amendment to a previous SEC Form 4 filing.
• The amendment corrects the number of shares sold on February 26, 2024, to cover tax withholding obligations related to vested performance stock units.
• The original filing incorrectly reported the sale of 1,185 shares in one instance and 1,218 shares in another, while the corrected numbers are 1,168 and 1,199 shares respectively.
• The corrected filing also adjusts the number of shares beneficially owned following the reported transactions to reflect the corrected sales figures.
• The transactions involved the acquisition of 3,366 and 6,914 shares of common stock on February 23, 2024, related to performance stock units granted on February 22, 2023.
• These performance stock units vest over time, with portions vesting on February 23, 2024, February 22, 2025, and February 22, 2026, assuming continued employment.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The amendment corrects an error, which is good for transparency. The 'sell to cover' transactions are routine and expected.

Positives

• The amendment demonstrates transparency and a commitment to accurate reporting by the company and its executives.
• The 'sell to cover' transactions indicate that the executive is receiving equity compensation, aligning their interests with those of shareholders.

Negatives

• The need for an amendment suggests an initial oversight in the reporting process.
• The sales of shares to cover tax obligations, while common, can exert downward pressure on the stock price.

Risks

• Inaccurate reporting, even if corrected, can erode investor confidence.
• Sales of shares to cover tax obligations could potentially dilute shareholder value if they occur frequently or in large volumes.

Future Outlook

The remaining performance stock units will be eligible to vest on 02/22/2025 and 02/22/2026, assuming continued employment.

Industry Context

SEC filings related to insider transactions are a routine part of the financial industry, providing transparency into the actions of company executives and their potential alignment with shareholder interests. Amendments to these filings, while not uncommon, highlight the importance of accuracy in financial reporting.

Comparison to Industry Standards

• Comparing Artivion's executive compensation and stock ownership to similar medical device companies like Medtronic or Boston Scientific would provide context.
• Analyzing the vesting schedules and performance metrics of Artivion's stock units against industry norms would be beneficial.
• Benchmarking the frequency and size of 'sell to cover' transactions against peers can indicate potential differences in executive compensation strategies or tax planning.

Stakeholder Impact

• Shareholders benefit from accurate and transparent reporting of insider transactions.
• Employees are impacted by the vesting of performance stock units, which are part of their compensation.

Key Dates